Levi C.M. Buil

Tumour-specific proline vulnerability uncovered by differential ribosome codon reading

Fabricio Loayza‐Puch, Koos Rooijers, Levi C.M. Buil et al. · Nature · 2016 · 276 citations · Full text

Tumor Biology, Tumour-specific Proline Vulnerability, Medicine +5

ABCB1, ABCG2, and PTEN Determine the Response of Glioblastoma to Temozolomide and ABT-888 Therapy

Fan Lin, Mark C. de Gooijer, Eloy Moreno Roig et al. · Clinical Cancer Research · 2014 · 137 citations

Antisense oligonucleotide-based treatment of retinitis pigmentosa caused by USH2A exon 13 mutations

Kalyan Dulla, Ralph Slijkerman, Hester C. van Diepen et al. · Molecular Therapy · 2021 · 135 citations · Full text

Improved Brain Penetration and Antitumor Efficacy of Temozolomide by Inhibition of ABCB1 and ABCG2

Mark C. de Gooijer, Nienke A. de Vries, Tessa Buckle et al. · Neoplasia · 2018 · 125 citations · Full text

P-glycoprotein and breast cancer resistance protein restrict the brain penetration of the CDK4/6 inhibitor palbociclib

Mark C. de Gooijer, Ping Zhang, Nishita Thota et al. · Investigational New Drugs · 2015 · 83 citations · Full text

Cdk4/6 Inhibitor Palbociclib, Medicine, Receptor Tyrosine Kinase +6